Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takayuki Abe

Showing results (151-160 of 269) with videos related to

Pageof 27
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 6, 2011
Is switching antidepressants following early nonresponse more beneficial in acute-phase treatment of depression?: a randomized open-label trialShinichiro Nakajima, Hiroyuki Uchida, Takefumi Suzuki, et al.
Journal of Virology|January 25, 2008
A single-amino-acid mutation in hepatitis C virus NS5A disrupting FKBP8 interaction impairs viral replicationToru Okamoto, Hiroko Omori, Yuuki Kaname, et al.
The Journal of Clinical Psychiatry|October 19, 2017
Placebo Effects in the Treatment of Noncognitive Symptoms of Alzheimer's Disease: Analysis of the CATIE-AD DataChisa Ozawa, Rachel Roberts, Kazunari Yoshida, et al.
Photochemistry and Photobiology|March 19, 2008
The lifetimes of Pharaonis phoborhodopsin signaling states depend on the rates of proton transfers--effects of hydrostatic pressure and stopped flow experimentsTakashi Kikukawa, Chabita K Saha, Sergei P Balashov, et al.
The Oncologist|October 19, 2018
Effectiveness of Antiemetic Regimens for Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Network Meta-AnalysisTakamichi Yokoe, Tetsu Hayashida, Aiko Nagayama, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 26, 2012
Combined hepatocellular carcinoma and neuroendocrine carcinoma with sarcomatous change of the liver after transarterial chemoembolizationChikashi Nakanishi, Koichiro Sato, Yasushi Ito, et al.
Rheumatology (Oxford, England)|June 14, 2025
Serum cytokine levels towards precision medicine in Still's disease: a subanalysis of a randomized controlled trial of tocilizumabKoji Suzuki, Hideto Kameda, Kei Ikeda, et al.
Autophagy Reports|May 21, 2025
Hepatitis C virus NS5A protein promotes the lysosomal degradation of diacylglycerol O-acyltransferase 1 (DGAT1) via endosomal microautophagyPutu Yuliandari, Chieko Matsui, Lin Deng, et al.
International Journal of Hematology|May 19, 2016
Efficacy and safety of rituximab in Japanese patients with acquired thrombotic thrombocytopenic purpura refractory to conventional therapyYoshitaka Miyakawa, Kazunori Imada, Tatsuo Ichinohe, et al.
Rheumatology (Oxford, England)|January 29, 2026
Long-term safety and efficacy of tocilizumab in adult-onset Still's disease: open-label, long-term extension of the phase III trialKoji Suzuki, Hideto Kameda, Kei Ikeda, et al.
Pageof 27

Showing results (151-160 of 269) with videos related to

Sort By:
Pageof 27
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 6, 2011
Is switching antidepressants following early nonresponse more beneficial in acute-phase treatment of depression?: a randomized open-label trialShinichiro Nakajima, Hiroyuki Uchida, Takefumi Suzuki, et al.
Journal of Virology|January 25, 2008
A single-amino-acid mutation in hepatitis C virus NS5A disrupting FKBP8 interaction impairs viral replicationToru Okamoto, Hiroko Omori, Yuuki Kaname, et al.
The Journal of Clinical Psychiatry|October 19, 2017
Placebo Effects in the Treatment of Noncognitive Symptoms of Alzheimer's Disease: Analysis of the CATIE-AD DataChisa Ozawa, Rachel Roberts, Kazunari Yoshida, et al.
Photochemistry and Photobiology|March 19, 2008
The lifetimes of Pharaonis phoborhodopsin signaling states depend on the rates of proton transfers--effects of hydrostatic pressure and stopped flow experimentsTakashi Kikukawa, Chabita K Saha, Sergei P Balashov, et al.
The Oncologist|October 19, 2018
Effectiveness of Antiemetic Regimens for Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Network Meta-AnalysisTakamichi Yokoe, Tetsu Hayashida, Aiko Nagayama, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 26, 2012
Combined hepatocellular carcinoma and neuroendocrine carcinoma with sarcomatous change of the liver after transarterial chemoembolizationChikashi Nakanishi, Koichiro Sato, Yasushi Ito, et al.
Rheumatology (Oxford, England)|June 14, 2025
Serum cytokine levels towards precision medicine in Still's disease: a subanalysis of a randomized controlled trial of tocilizumabKoji Suzuki, Hideto Kameda, Kei Ikeda, et al.
Autophagy Reports|May 21, 2025
Hepatitis C virus NS5A protein promotes the lysosomal degradation of diacylglycerol O-acyltransferase 1 (DGAT1) via endosomal microautophagyPutu Yuliandari, Chieko Matsui, Lin Deng, et al.
International Journal of Hematology|May 19, 2016
Efficacy and safety of rituximab in Japanese patients with acquired thrombotic thrombocytopenic purpura refractory to conventional therapyYoshitaka Miyakawa, Kazunori Imada, Tatsuo Ichinohe, et al.
Rheumatology (Oxford, England)|January 29, 2026
Long-term safety and efficacy of tocilizumab in adult-onset Still's disease: open-label, long-term extension of the phase III trialKoji Suzuki, Hideto Kameda, Kei Ikeda, et al.
Pageof 27